Aurora Cannabis Inc. (ACB): Price and Financial Metrics


Aurora Cannabis Inc. (ACB): $1.06

-0.07 (-6.19%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ACB POWR Grades

  • Growth is the dimension where ACB ranks best; there it ranks ahead of 66.3% of US stocks.
  • The strongest trend for ACB is in Stability, which has been heading down over the past 177 days.
  • ACB ranks lowest in Momentum; there it ranks in the 0th percentile.

ACB Stock Summary

  • In terms of twelve month growth in earnings before interest and taxes, AURORA CANNABIS INC is reporting a growth rate of 187.3%; that's higher than 91.73% of US stocks.
  • Revenue growth over the past 12 months for AURORA CANNABIS INC comes in at -19.8%, a number that bests just 9.3% of the US stocks we're tracking.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ACB comes in at -52.82% -- higher than that of merely 9.46% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to AURORA CANNABIS INC are ADMA, VEV, AGIL, KORE, and HLBZ.
  • Visit ACB's SEC page to see the company's official filings. To visit the company's web site, go to auroramj.com.

ACB Price Target

For more insight on analysts targets of ACB, see our ACB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $8.07 Average Broker Recommendation 2.32 (Moderate Sell)

ACB Stock Price Chart Interactive Chart >

Price chart for ACB

ACB Price/Volume Stats

Current price $1.06 52-week high $4.90
Prev. close $1.13 52-week low $0.82
Day low $1.05 Volume 8,812,000
Day high $1.14 Avg. volume 7,776,800
50-day MA $1.05 Dividend yield N/A
200-day MA $1.51 Market Cap 343.79M

Aurora Cannabis Inc. (ACB) Company Bio


Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products as is headquartered in Calgary, Canada. Aurora is a vertically integrated company, owning all aspects of the cannabis production process from scientific research and cultivation to product branding and distribution. The company’s marketing strategy focuses on three main segments of the cannabis market: Canadian, EU, and select global medical markets, Canadian recreational cannabis market, and the US hemp-driven market. Aurora operates licensed production facilities in Alberta, Ontario, British Columbia, and Denmark and maintains a workforce of over 2,700 employees. Miguel Martin serves as Aurora’s Chief Executive Officer.


ACB Latest News Stream


Event/Time News Detail
Loading, please wait...

ACB Latest Social Stream


Loading social stream, please wait...

View Full ACB Social Stream

Latest ACB News From Around the Web

Below are the latest news stories about AURORA CANNABIS INC that investors may wish to consider to help them evaluate ACB as an investment opportunity.

Why SNDL, Aurora Cannabis, and Tilray Stocks Popped Today

There's more evidence now favoring medical marijuana legalization. But medical marijuana is already legal in most states.

Yahoo | February 2, 2023

Is Aurora Cannabis (ACB) Outperforming Other Medical Stocks This Year?

Here is how Aurora Cannabis Inc. (ACB) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.

Yahoo | January 31, 2023

Can Aurora Cannabis Stock Deliver 10X Returns by 2033?

First off, a massive valuation gap must exist between a company's current share price and its fair value estimate. Under normal circumstances, the market is fairly efficient at pricing equities, but sizable valuation gaps can form when Wall Street has serious doubts about a company's business model. Second, and perhaps most importantly, the company must be able to build a solid competitive moat to protect profits over the long-term.

Yahoo | January 30, 2023

Aurora Cannabis to Host Second Quarter Fiscal Year 2023 Investor Conference Call

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2023 on Thursday, February 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will report its financial results for the second quarter fiscal year 2023 after the close of markets that same day.

Yahoo | January 26, 2023

Why Aurora Cannabis Stock Is Fading Today

With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today.

Yahoo | January 25, 2023

Read More 'ACB' Stories Here

ACB Price Returns

1-mo 20.32%
3-mo -21.48%
6-mo -29.33%
1-year -74.82%
3-year -95.59%
5-year -99.04%
YTD 14.89%
2022 -82.95%
2021 -34.90%
2020 -67.94%
2019 -56.45%
2018 -34.99%

Continue Researching ACB

Here are a few links from around the web to help you further your research on Aurora Cannabis Inc's stock as an investment opportunity:

Aurora Cannabis Inc (ACB) Stock Price | Nasdaq
Aurora Cannabis Inc (ACB) Stock Quote, History and News - Yahoo Finance
Aurora Cannabis Inc (ACB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9802 seconds.